Published On: Thu, Feb 18th, 2021

Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US

Tagged with: | | | |

Dr. Reddy’s Laboratories, an Indian pharma company, has launched , USP, in the US market.

Fluphenazine Hydrochloride Tablets, USP is a therapeutic equivalent generic version of Prolixin Tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg, which has approval from the US (FDA) for the management of manifestations of psychotic disorders.

The Prolixin brand and generic had sales of around $134 million MAT in the US for the most recent 12 months ending in December 2020 as per National Sales Perspective: Retail and Non-Retail MAT December 2020.

Dr. Reddy’s Laboratories said that its Fluphenazine Hydrochloride Tablets, USP are available in 100 bottle count sizes in the dosages of 1 mg, 2.5 mg, 5 mg, and 10 mg tablets.

Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US

Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US. Photo courtesy of Arichuvadi/Wikipedia.org.

Related posts